期刊文献+

PPAR-γ通过PI3K/Akt及NF-κB通路调控猪颈动脉支架植入术后的血管重构

PPAR-γ regulates vascular remodeling after pig carotid artery stent implantation through PI3K/Akt and NF-κB pathway
下载PDF
导出
摘要 目的观察过氧化物酶体增殖物激活受体-γ(peroxisome proliferator activated receptors-γ,PPAR-γ)在猪颈动脉支架植入术后血管重构中的作用。方法将12只小型猪分为正常对照组(n=4)和介入手术组(n=8),介入手术组采用猪颈动脉支架植入建立动物模型,分为支架组(n=4)和罗格列酮(ROSI)组(n=4)。术后3个月,应用数字减影血管造影(digital subtraction angiography,DSA)技术及HE染色评估血管形态学变化,应用免疫组织化学方法检测p-Akt及NF-κB的表达变化,应用Western blot方法检测支架段血管PPAR-γ、Akt、p-Akt及NF-κB的表达变化。结果①猪颈动脉DSA和HE染色结果发现支架组血管狭窄较ROSI组明显(P<0.01)。②免疫组织化学染色结果发现支架组颈动脉血管p-Akt和NF-κB表达较正常对照组明显增加(P<0.01),ROSI组颈动脉血管p-Akt和NF-κB表达较支架组明显降低(P<0.01)。③Western blot检测结果显示:支架组PPAR-γ蛋白表达水平较正常对照组明显降低(P<0.01),NF-κB和p-Akt蛋白表达水平较正常对照组明显增加(P<0.05);ROSI组PPAR-γ蛋白表达水平较支架组明显增加(P<0.01),NF-κB和p-Akt蛋白表达水平较支架组明显降低(P<0.01);Akt在正常对照组、支架组和ROSI组中的蛋白表达量差异无统计学意义(P>0.05)。结论 PPAR-γ可能通过调节PI3K/Akt及NF-κB的表达,从而改善支架植入术后的血管重构。 Objective To determine the role of peroxisome proliferator activated receptors-γ (PPAR-γ) in swine vascular remodeling after carotid artery stent implantation. Methods Totally 12 miniature pigs were randomly divided into normal control group (n=4) and intervention group (n=8). The animals of intervention group were adopted to establish the animal model of carotid artery stenting, and then randomly divided into stent subgroup (n=4) and rosiglitazone treatment (ROSI) subgroup (n=4). In 3 months after surgery, digital subtraction angiography (DSA) and HE staining was used to assess vascular morphology, immunohistochemical staining was applied to detect the expression of P-akt and NF-κB, and Western blotting was employed to detect the expression of PPAR-γ, Akt, p-Akt and NF-κB. Results DSA and HE staining demonstrated that vascular stenosis was more severe in the stent subgroup than the ROSI group (P〈0.01). Immunohistochemical staining showed that the expression of p-Akt and NF-κB were significantly increased in the carotid artery stent groups than normal control group (P〈0.01), and that in ROSI subgroup was significantly lower than in the stent subgroup (P〈0.01). Western blot analysis showed that the protein expression level of PPAR-γ was significantly lower (P〈0.01), and those of NF-κB and p-Akt were obviously higher in the stent subgroup than the normal control group (P〈0.05), while that of PPAR-γ was significantly enhanced (P〈0.01), and those of NF-κB and p-Akt were markedly reduced in the ROSI subgroup than in the stent subgroup (P〈0.01). However, there was no significant difference in the protein expression of Akt in normal control group, stent subgroup and ROSI subgroup (P〉0.05). Conclusion PPAR-γ might mediate the expression of PI3K/Akt and NF-κB, and then improve the vascular remodeling after stent implantation.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2014年第9期888-892,共5页 Journal of Third Military Medical University
基金 国家自然科学基金面上项目(81271672)~~
关键词 过氧化物酶体增殖物激活受体-Γ Akt P-AKT NF-ΚB 血管重构 peroxisome proliferator activated receptors-γ Akt p-Akt NF-κB vascular remodeling swine
  • 相关文献

参考文献15

  • 1Millar J S. Novel benefits of peroxisome proliferator-activated receptors on cardiovascular risk [ J ]. Curr Opin Lipidol, 2013, 24 ( 3 ) : 233 238.
  • 2Zhang L, Xie P, Wang J, et al. Impaired peroxisome proliferator-acti- vated receptor-gamma contributes to phenotypie modulation of vascular smooth muscle ceils during hypertension[ J]. J Biol Chem, 2010, 285(18): 13666- 13677.
  • 3Shinke T, Geva S, Pendyala L, et al. Low-dose paclitaxel elution by novel bioerodible sol-gel coating on stents inhibits neointima with low toxicity in porcine coronary arteries [ J ]. Int J Cardiol, 2009, 135 ( 1 ) : 93 - 101.
  • 4Krajewski S, Krajewska M, Shabaik A, et al determination of in vivo distribution of Bax, a dominant inhibitor of Bcl- 2[J]. Am J Pathol, 1994, 145(6) : 1323 -1336.
  • 5杨源瑞,郑波,周振华,吴虹辰,刘渠,陈康宁.猪颈动脉支架植入术后PPAR-γ的表达变化及对血管平滑肌表型转化的影响[J].第三军医大学学报,2014,36(4):321-325. 被引量:5
  • 6Puato M, Piergentili C, Zanardo M, et al. Vascular remodeling after carotid artery stenting[ J ]. Angiology, 2007, 58 (5) : 565 - 571.
  • 7许海燕,乔树宾,李建军,杨跃进,张家芬,徐波,谢高强,董秋婷.炎症和血脂控制对冠状动脉介入治疗术后血管病变的不同影响[J].中华医学杂志,2009,89(32):2249-2252. 被引量:17
  • 8Hamblin M, Chang L, Fan Y, et al. PPARs and the cardiovascular system [J]. Antioxid Redox Signal, 2009, 11 (6) : 1415 -1452.
  • 9Beyer A M, Baumbach G L, Halabi C M, et al. Interference with PPARgamma signaling causes cerebral vascular dysfunction, hypertro- phy, and remodeling[ J ]. Hypertension, 2008, 51 (4) : 867 - 871.
  • 10Olefsky J M, Glass C K. Macrophages, inflammation, and insulin re- sistance[J]. Annu Rev Physiol, 2010, 72:219 -246.

二级参考文献24

  • 1Mitra AK, Agrawal DK. In stent restenosis : bane of the stent era. J Clin Pathol, 2006,59:232-239.
  • 2Stoll G, Bendszus M. Inflammation and atherosclerosis: novel insights into plaque formation and destabilization. Stroke, 2006, 37 : 1923 -1932.
  • 3Pamukeu B, Oflaz H, Nisanei Y. The role of platelet glyeoprotein Ⅲ a polymorphism in the high prevalence of in vitro aspirin resistance in patients with intracoronary stent restenosis. Am Heart J, 2005 ,149:675-680.
  • 4Mann J, Davies MJ. Mechanisms of progression in native coronary artery disease: role of healed plaque disruption. Heart, 1999,82 : 265 -268.
  • 5Kim E J, Rha SW, Wani SP, et al. Coronary stent fracture and restenosis in the drug-eluting stent era: do we have clues of management? Int J Cardiol, 2007, 120:417-419.
  • 6Wilson PW. Evidence of systemic inflammation and estimation of coronary artery disease risk: a population perspective. Am J Med, 2008,121 : S15-S20.
  • 7Bonnet J, McPherson R, Tedgui A, et al. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects ) study. Clin Ther, 2008,30:2298-2313.
  • 8Chyrchel M, Rakowski T, Rzeszutko L,et al. Effects of high-dose statin administered prior to coronary angioplasty on the incidence of cardiac events in patients with acute coronary syndrome. Kardiol Pol, 2006,64 : 1357-1362.
  • 9Ridker PM, Danielson E, Fonseca FA, et al. JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med, 2008,359:2195- 2207.
  • 10George U,Santhosh K,Pandian J. Current status of stenting in intracranial atherosclerotic disease:the story thus far and the way ahead[J].{H}NEUROLOGY INDIA,2011,(3):383-389.

共引文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部